May 04, 2023 / 11:00AM GMT
Jonas Jarvius - Q-linea AB - CEO
Thank you very much for that, and welcome everyone to our report for the first quarter in 2023. So we'll go right into the presentation, but we start with our disclaimer slide in case me or Chris would make any forward-looking statements during this call.
I will now present a little bit high level of what we have seen activities in the first quarter. I will then weigh in a little bit deeper on why we're developing the products we are and the value of those products. I will then actually make a little bit of a resume of our actions that happened since Thermo Fisher, and we decided to end our partnership up until today, and then give a little bit of a look on the future.
But here, you can see on the first slide, we're basically summarizing what has happened. And as you know, we're developing solutions for disruptive infectious disease diagnostics.
And we have been working hard during this first quarter to implement our new commercialization strategy. Part of that strategy is, of course, also to have sign-up distributors for key countries, also
Q1 2023 Q linea AB Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers